High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)-Reference-Cited by-同舟云学术

High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)

Published:2005-05-23 Issue:1 Volume:36 Page:25-31
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Bengala C, ,Guarneri V,Ledermann J,Rosti G,Wandt H,Lotz J-P,Cure J H,Orlandini C,Ferrante P,Conte P F,Demirer T

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705007.pdf

Reference30 articles.

1. Ozols RF . Management of advanced ovarian cancer consensus summary. Advanced Ovarian Cancer Consensus Faculty. Semin Oncol 2000; 27 (Suppl. 7): 47–49.

2. Conte PF, Cianci C, Gadducci A . Update in the management of advanced ovarian carcinoma. Crit Rev Oncol Hematol 1999; 32: 49–58.

3. Bruzzone M, Repetto L, Chiara S et al. Chemotherapy vs radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look. Gynecol Oncol 1990; 38: 392–395.

4. Varia MA, Stehman FB, Bundy BN et al. Intraperitoneal radioactive phosphorus (32P) vs observation after negative second-look laparoptomy for stage III ovarian carcinoma: a randomised trial of the gynaecologic oncology group. J Clin Oncol 2003; 21: 2849–2855.

5. Markman M, Liu PY, Wilczynski S et al. Phase III randomized trial of 12 vs 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group trial. J Clin Oncol 2003; 21: 2460–2465.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epithelial Ovarian Cancer;Clinical Gynecologic Oncology;2018

2. Epithelial Ovarian Cancer;Clinical Gynecologic Oncology;2012

3. The inverted pyramid of biomarker-driven trials;Nature Reviews Clinical Oncology;2011-08-02

4. Allogeneic hematopoietic stem cell transplantation in ovarian cancer-the EBMT experience;International Journal of Cancer;2010-01-04

5. Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases;Supportive Care in Cancer;2009-10-20